advertisement
Abstract #6194 Published in IGR 2-2
Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment
Stjernschantz J; Selen G; Astin M; Resul BProgress in Retinal and Eye Research 2000; 19: 459-496
Prostaglandin F(2α) analogues have recently been introduced onto the market for glaucoma treatment. While these drugs have a well-documented intraocular pressure reducing effect, only a limited number of studies have been published regarding their effects on the microvasculature in the eye. Since many naturally occurring prostaglandins have marked effects on the cardiovascular system, it is conceivable that synthetic prostaglandins used as glaucoma drugs may exert microvascular effects in the eye, even if they exhibit receptor selectivity. Latanoprost, the active principle of Xalatan® eye drops, is a selective FP prostanoid receptor agonist, and much of the paper is focused on the microvascular effects of latanoprost and some closely related prostaglandin analogues. The purpose of this paper is to review the literature on the microvascular effects of prostaglandins in the eye, and to present some unpublished data on the effects of selective prostaglandin analogues. Most of the prostaglandin analogues studied exhibit selectivity for the FP prostanoid receptor. Results from studies with the following prostaglandin analogues are presented in the paper: PGF(2α)-isopropyl ester (PGF(2α)-IE), 17-phenyl-18,19,20-trinor-PGF(2α)-isopropyl ester (17-phenyl-PGF (2a)-IE), 15-keto-17-phenyl-18,19, 20-trinor-PGF(2α)-isopropyl ester (15-keto-17-phenyl-PGF(2a)-IE), 13,14-dihydro-17-phenyl-18,19,20-trinor-PGF(2α)-isopropy l ester (latanoprost), 13,14-dihydro-15R,S-17-phenyl-18,19, 20-trinor-PGF (2α)-isopropyl ester (PhXA34), 17-phenyl-18,19, 20-trinor-PGE (2)-isopropyl ester (17-phenyl-PGE(2)-IE), and 19R-hydroxy-PGE(2) (19R-OH-PGE(2)). The regional blood flow has been determined with radioactively labelled microspheres, the blood volume with (51)Cr labelled erythrocytes and the capillary permeability to albumin with (125)I and (131)I labelled albumin. PGF(2α)-IE has been shown to exert marked microvascular effects in the rabbit anterior segment including vasodilatation, increased capillary permeability, and a breakdown of the blood-aqueous barrier. 17-phenyl-PGF(2α)-IE, 15-keto-17-phenyl-PGF(2α)-IE, and PhXA34/latanoprost exerted significantly less vasodilatory effect, and little effect on capillary permeability was seen with the FP receptor agonists when studied with Evans blue. Intravenous administration of PhXA34 at a dose range of 1-100 mgr/kg b.w. had no consistent effect on the regional blood flow in the eye indicating that FP receptors in the ocular blood vessels are not expressed in the rabbit, or alternatively are not functionally coupled to regulation of vascular tone.In cats topical application of PGF(2α)-IE had no significant effect the on the regional blood flow in cannulated eyes. No blood flow experiments were performed in intact eyes with PGF(2α)-IE. 17-phenyl-PGF(2α)-IE and latanoprost caused some vasodilation in the anterior segment. None of the analogues had any significant effect on the blood volume in the ocular tissues, but an increase in capillary permeability to albumin was seen in several tissues of the eye. However, in the eyelid, nictitating membrane and conjunctiva exposed to high concentrations of the prostaglandins, no or only a small amount of leakage of albumin was detected. It appears that the intraocular microvasculature in the cat exhibits some sensitivity to FP prostanoid receptor agonists.
Dr. J. Stjernschantz, Department of Neuroscience, Unit of Pharmacology, Uppsala University, Sweden. johan.stjernschantz@neuro.uu.se
Classification:
11.4 Prostaglandins (Part of: 11 Medical treatment)
